On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....